Skip to main content

Table 3 Risk ratios (RR) and their 95 % confidence intervals (CI) from Cox model for association of fibrinogen on MetS in female overweight, dyslipidemia, hypertension and hyperglycemia sub-cohorts

From: A new insight into the role of plasma fibrinogen in the development of metabolic syndrome from a prospective cohort study in urban Han Chinese population

 

Overweight (n = 717)

Dyslipidemia (n = 483)

Hypertension (n = 511)

Hyperglycemia (n = 115)

Fibrinogen quartiles

 Q2 vs. Q1

1.67 (0.98,2.84)

1.28 (0.65,2.54)

0.90 (0.50,1.62)

0.77 (0.24,2.51)

 Q3 vs. Q1

1.69 (1.02,2.81)

1.49 (0.78,2.84)

1.07 (0.63,1.84)

1.26 (0.46,3.43)

 Q4 vs. Q1

1.97 (1.20,3.23)

1.44 (0.75,2.76)

1.10 (0.65,1.85)

0.77 (0.30,1.97)

Age

1.03 (1.02,1.05)

1.04 (1.02,1.07)

1.02 (1.00,1.03)

1.03 (1.00,1.07)

Smoking

0.92 (0.63,1.35)

1.25 (0.75,2.07)

1.00 (0.67,1.47)

1.60 (0.71,3.59)

Frequent drinker

0.72 (0.33,1.58)

0.38 (0.11,1.39)

0.97 (0.48,1.97)

3.24 (0.69,15.1)

Vegetarian

0.78 (0.57,1.05)

0.98 (0.65,1.49)

0.82 (0.59,1.13)

0.76 (0.37,1.56)

Regular exerciser

0.77 (0.57,1.03)

0.82 (0.55,1.22)

1.08 (0.79,1.48)

1.02 (0.52,2.01)

Overweight

 

4.34 (2.52,7.47)

4.18 (2.63,6.66)

2.89 (1.07,7.83)

Dyslipidemia

2.59 (1.70,3.94)

 

3.26 (1.87,5.69)

1.64 (0.52,5.17)

Hypertension

2.94 (1.98,4.34)

3.49 (1.89,6.45)

 

2.22 (0.79,6.24)

Hyperglycemia

3.29 (1.75,6.18)

3.16 (1.25,7.98)

4.09 (2.11,7.95)

Â